GILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share Certificates01-12-2023
GILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share CertificatesGILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate Share CertificateGILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Loss of Share CertificatesGILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper PublicationGILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Newspaper PublicationGILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Outcome Of The Board Meeting For The Quarter Ended On 30Th September, 2023
Outcome of Board Meeting for the quarter ended 30th September, 2023GILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of the Board Meeting in terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015GILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Duplicate Share CertificateGILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation for Loss of Share CertificateGILLANDERS ARBUTHNOT & CO.LTD. - 532716 - Board Meeting Intimation for Considering, Approval And Taking On Record The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September, 2023 Along With The Limited Review Report Thereon
GILLANDERS ARBUTHNOT & CO.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2023 along with the Limited Review Report thereon